Treatment of ovarian tumor cells with SCD1/FADS2 inhibitors in combination with ferroptosislatin can raise the rate of apoptosis, decrease the rate of cell mobility and tumor metastasis, and increase the sensitivity of ovarian tumor cells to ferroptosislatin (54). Here, SCD is linked to neoplasm.